Myostatin and muscle atrophy during chronic kidney disease

Chronic kidney disease (CKD) patients often exhibit a low muscle mass and strength, leading to physical impairment and an increased mortality. Two major signalling pathways control protein synthesis, the insulin-like growth factor-1/Akt (IGF-1/Akt) pathway, acting as a positive regulator, and the my...

Full description

Bibliographic Details

Published in:	Nephrology, dialysis, transplantation Vol. 36; no. 11; p. 1986
Main Authors:	Bataille, Stanislas, Chauveau, Philippe, Fouque, Denis, Aparicio, Michel, Koppe, Laetitia
Format:	Journal Article
Language:	English
Published:	England 09.11.2021
Subjects:	Humans Muscle, Skeletal Muscular Atrophy - etiology Myostatin Renal Dialysis Renal Insufficiency, Chronic - therapy Uremic Toxins wasting chronic kidney disease myostatin sarcopenia
ISSN:	1460-2385, 1460-2385
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!